An in silico canine cardiac midmyocardial action potential duration model as a tool for early drug safety assessment
The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
Cell lines expressing ion channels (IC) and the advent of plate-based electrophysiology device have enabled a molecular understanding of the action potential (AP) as a means of early QT assessment. We sought to develop an in silico AP (isAP) model that provides an assessment of the effect of a compound on the myocyte AP duration (APD) using concentration-effect curve data from a panel of five ICs (hNav1.5, hCav1.2, hKv4.3/hKChIP2.2, hKv7.1/hminK, hKv11.1). A test set of 53 compounds was selected to cover a range of selective and mixed IC modulators that were tested for their effects on optically measured APD. A threshold of >10% change in APD at 90% repolarization (APD 90) was used to signify an effect at the top test concentration. To capture the variations observed in left ventricular midmyocardial myocyte APD data from 19 different dogs, the isAP model was calibrated to produce an ensemble of 19 model variants that could capture the shape and form of the APs and also quantitatively replicate dofetilide- and diltiazem-induced APD 90 changes. Provided with IC panel data only, the isAP model was then used, blinded, to predict APD 90 changes greater than 10%. At a simulated concentration of 30 μM and based on a criterion that six of the variants had to agree, isAP prediction was scored as showing greater than 80% predictivity of compound activity. Thus, early in drug discovery, the isAP model allows integrating separate IC data and is amenable to the throughput required for use as a virtual screen.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Laverty, H., Benson, C., Cartwright, E., Cross, M., Garland, C., Hammond, T., Holloway, C., McMahon, N., Milligan, J., Park, B., et al. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01255.x · Cited by 363
Self-citationSzabó, G., Szentandrássy, N., Bíró, T., Tóth, B. I., Czifra, G., Magyar, J., Bányász, T., Varró, A., Kovács, L., & Nánási, P. P. (2005) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-005-1445-z · Cited by 134 · cited 1×
“Model mean I-V curve of the 19 variants is shown in blue, and experimental data extracted from publications are overlaid and shown in black (35a, 46) and green (49).”
Method
Cited by
Sager, P. T., Gintant, G., Turner, J. R., Pettit, S., & Stockbridge, N. (2014) · American Heart Journal · doi:10.1016/j.ahj.2013.11.004 · Cited by 540
Passini, E., Britton, O. J., Lu, H. R., Rohrbacher, J., Hermans, A. N., Gallacher, D. J., Greig, R. J. H., Bueno-Orovio, A., & Rodriguez, B. (2017) · Frontiers in Physiology · doi:10.3389/fphys.2017.00668 · Cited by 326
Britton, O. J., Bueno-Orovio, A., Van Ammel, K., Lu, H. R., Towart, R., Gallacher, D. J., & Rodriguez, B. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1304382110 · Cited by 314
Carusi, A., Burrage, K., & Rodríguez, B. (2012) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.01151.2011 · Cited by 102
“The current maturity of the MSE system in cardiac electrophysiology opens up new perspectives for the potential of computational cardiac electrophysiology for the refinement, reduction, and replacement of animal experiments in research as well as in industrial applications such as drug development (29, 35, 59, 89).”
BackgroundRecent developments in using mechanistic cardiac modelling for drug safety evaluation
Davies, M. R., Wang, K., Mirams, G. R., Caruso, A., Noble, D., Walz, A., Lavé, T., Schuler, F., Singer, T., & Polonchuk, L. (2016) · Drug Discovery Today · doi:10.1016/j.drudis.2016.02.003 · Cited by 66
Self-citation
Metadata
- Authors
- Davies, M. R., Mistry, H. B., Hussein, L., Pollard, C. E., Valentin, J.-P., Swinton, J., & Abi-Gerges, N.
- Venue
- American Journal of Physiology-Heart and Circulatory Physiology
- Publisher
- American Physiological Society
- Published
- 2012-04-01
- Volume
- 302
- Issue
- 7
- Pages
- H1466-H1480
- ISSN
- 0363-6135 (ISSN-L)
- 1522-1539
- OpenAlex
- W2099823887
- Cited by
- 83
- References
- 2
- FWCI
- 5.54
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.